Regeneron Pharmaceuticals announced that it will pick the top two antibodies out of hundreds it has identified for the development of a cocktail treatment that may be used to potentially treat or prevent COVID-19, with the company planning to launch clinical trials by early summer.
Regeneron planning a coronavirus cocktail treatment
Sign up for AIChE SmartBrief
News for chemical engineers
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.